Assembly

Choose networks to assemble for the query. All public networks, networks that you have uploaded, and networks shared with projects in which you participate are shown.

Name Version Created
20392114 2.0.8 2018-12-11 07:05:51
30232325(1).bel 2.0.1 2018-12-11 07:20:33
30232325(2).bel 2.0.1 2018-12-11 07:38:38
30232325.bel 2.0.4 2018-12-11 09:04:38
AB_Test1 1.1.1 2018-12-05 09:38:10
AB_Test2 1.1.1 2018-12-05 10:34:15
Angiogenesis-2.0-Hs 2.0 2018-04-03 15:02:30
Angiogenesis-2.0-Mm 2.0 2018-04-03 15:08:09
Angiogenesis-2.0-Rn 2.0 2018-04-03 15:14:04
Apoptosis-2.0-Hs 2.0 2018-04-03 15:02:41
Apoptosis-2.0-Mm 2.0 2018-04-03 15:08:24
Apoptosis-2.0-Rn 2.0 2018-04-03 15:14:17
Autophagy-2.0-Hs 2.0 2018-04-03 15:02:49
Autophagy-2.0-Mm 2.0 2018-04-03 15:08:32
Autophagy-2.0-Rn 2.0 2018-04-03 15:14:25
B-cell Signaling-2.0-Hs 2.0 2018-04-03 15:02:56
B-cell Signaling-2.0-Mm 2.0 2018-04-03 15:08:38
B-cell Signaling-2.0-Rn 2.0 2018-04-03 15:14:34
BEL Framework Example 1 Document 20150611 2018-03-29 14:17:21
BEL Framework Example 2 Document 20150611 2018-03-30 17:34:03
BEL Framework Example 3 Document 2015611 2018-03-30 18:28:11
BEL Framework Large Corpus Document 20170611 2018-03-30 17:30:20
BEL Framework Small Corpus Document 20150611 2018-03-30 17:35:22
BEL Training sentences edited 1.1.8 2018-12-06 10:35:17
Calcium-2.0-Hs 2.0 2018-04-03 15:03:02
Calcium-2.0-Mm 2.0 2018-04-03 15:08:44
Calcium-2.0-Rn 2.0 2018-04-03 15:14:39
CDR-SB Associations 1.0.5 2018-04-03 14:59:53
Cell Cycle-2.0-Hs 2.0 2018-04-03 15:03:10
Cell Cycle-2.0-Mm 2.0 2018-04-03 15:08:51
Cell Cycle-2.0-Rn 2.0 2018-04-03 15:14:47
Cell Interaction-2.0-Hs 2.0 2018-04-03 15:03:17
Cell Interaction-2.0-Mm 2.0 2018-04-03 15:08:58
Cell Interaction-2.0-Rn 2.0 2018-04-03 15:14:54
Clock-2.0-Hs 2.0 2018-04-03 15:03:23
Clock-2.0-Mm 2.0 2018-04-03 15:09:03
Clock-2.0-Rn 2.0 2018-04-03 15:15:00
coioagnriolytar_497.1.txt 1.0 2020-02-04 18:27:05
coioagnriolytar_497.3.txt 1.0 2020-02-04 18:37:05
coioagnriolytar_497.4.txt 1.0 2020-02-04 18:41:24
colorectal cancer Knowledge Assembly - Drugs 1.0.1 2018-09-11 15:36:09
Colorectal Cancer Knowledge Assembly - Drugs Pathways 1.0.0 2018-09-11 15:34:46
Colorectal Cancer Model 2.0.6 2018-11-30 09:05:42
CRC_combined 1.1 2018-09-11 20:15:47
CRC_combined.bel 1.0 2018-09-11 17:53:47
Cytotoxic T-cell Signaling-2.0-Hs 2.0 2018-04-03 15:03:28
Cytotoxic T-cell Signaling-2.0-Mm 2.0 2018-04-03 15:09:09
Cytotoxic T-cell Signaling-2.0-Rn 2.0 2018-04-03 15:15:06
Dendritic Cell Signaling-2.0-Hs 2.0 2018-04-03 15:03:35
Dendritic Cell Signaling-2.0-Mm 2.0 2018-04-03 15:09:16
Dendritic Cell Signaling-2.0-Rn 2.0 2018-04-03 15:15:14
DR_1 1.1.1 2018-12-05 10:50:48
ECM Degradation-2.0-Hs 2.0 2018-04-03 15:03:42
ECM Degradation-2.0-Mm 2.0 2018-04-03 15:09:23
ECM Degradation-2.0-Rn 2.0 2018-04-03 15:15:21
Endoplasmic Reticulum Stress-2.0-Hs 2.0 2018-04-03 15:03:48
Endoplasmic Reticulum Stress-2.0-Mm 2.0 2018-04-03 15:09:29
Endoplasmic Reticulum Stress-2.0-Rn 2.0 2018-04-03 15:15:27
Endothelial Innate Immune Activation-2.0-Hs 2.0 2018-04-03 15:03:57
Endothelial Innate Immune Activation-2.0-Mm 2.0 2018-04-03 15:09:38
Endothelial Innate Immune Activation-2.0-Rn 2.0 2018-04-03 15:15:35
Epigenetics-2.0-Hs 2.0 2018-04-03 15:04:03
Epigenetics-2.0-Mm 2.0 2018-04-03 15:09:44
Epigenetics-2.0-Rn 2.0 2018-04-03 15:15:41
Epithelial Innate Immune Activation-2.0-Hs 2.0 2018-04-03 15:04:13
Epithelial Innate Immune Activation-2.0-Mm 2.0 2018-04-03 15:09:53
Epithelial Innate Immune Activation-2.0-Rn 2.0 2018-04-03 15:15:52
Epithelial Mucus Hypersecretion-2.0-Hs 2.0 2018-04-03 15:04:22
Epithelial Mucus Hypersecretion-2.0-Mm 2.0 2018-04-03 15:10:02
Epithelial Mucus Hypersecretion-2.0-Rn 2.0 2018-04-03 15:16:01
Exported from Bel-c 10.bel 2.0.4 2020-02-04 19:05:01
Exported from Bel-c 15.bel 2.0.4 2020-02-04 19:11:57
Exported from Bel-c.bel 2.0.4 2020-02-04 18:46:23
Exported from Bel-c1.bel 2.0.4 2020-02-04 18:53:02
fc34ba14-6a91-4142-811b-cacad7ad64ce_3150.txt 1.0 2018-08-29 19:01:04
Fibrosis-2.0-Hs 2.0 2018-04-03 15:04:31
Fibrosis-2.0-Mm 2.0 2018-04-03 15:10:15
Fibrosis-2.0-Rn 2.0 2018-04-03 15:16:11
Growth Factor-2.0-Hs 2.0 2018-04-03 15:04:41
Growth Factor-2.0-Mm 2.0 2018-04-03 15:10:27
Growth Factor-2.0-Rn 2.0 2018-04-03 15:16:22
Hedgehog-2.0-Hs 2.0 2018-04-03 15:04:47
Hedgehog-2.0-Mm 2.0 2018-04-03 15:10:34
Hedgehog-2.0-Rn 2.0 2018-04-03 15:16:28
Hox-2.0-Hs 2.0 2018-04-03 15:04:52
Hox-2.0-Mm 2.0 2018-04-03 15:10:40
Hox-2.0-Rn 2.0 2018-04-03 15:16:33
Hypoxic Stress-2.0-Hs 2.0 2018-04-03 15:05:00
Hypoxic Stress-2.0-Mm 2.0 2018-04-03 15:10:46
Hypoxic Stress-2.0-Rn 2.0 2018-04-03 15:16:40
Immune Regulation of Tissue Repair-2.0-Hs 2.0 2018-04-03 15:05:09
Immune Regulation of Tissue Repair-2.0-Mm 2.0 2018-04-03 15:10:56
Immune Regulation of Tissue Repair-2.0-Rn 2.0 2018-04-03 15:16:50
Jak Stat-2.0-Hs 2.0 2018-04-03 15:05:15
Jak Stat-2.0-Mm 2.0 2018-04-03 15:11:05
Jak Stat-2.0-Rn 2.0 2018-04-03 15:16:57
Macrophage Signaling-2.0-Hs 2.0 2018-04-03 15:05:24
Macrophage Signaling-2.0-Mm 2.0 2018-04-03 15:11:15
Macrophage Signaling-2.0-Rn 2.0 2018-04-03 15:17:06
Mapk-2.0-Hs 2.0 2018-04-03 15:05:30
Mapk-2.0-Mm 2.0 2018-04-03 15:11:22
Mapk-2.0-Rn 2.0 2018-04-03 15:17:12
Mast cell activation-2.0-Hs 2.0 2018-04-03 15:05:36
Mast cell activation-2.0-Mm 2.0 2018-04-03 15:11:28
Mast cell activation-2.0-Rn 2.0 2018-04-03 15:17:18
Megakaryocyte Differentiation-2.0-Hs 2.0 2018-04-03 15:05:43
Megakaryocyte Differentiation-2.0-Mm 2.0 2018-04-03 15:11:36
Megakaryocyte Differentiation-2.0-Rn 2.0 2018-04-03 15:17:26
mTor-2.0-Hs 2.0 2018-04-03 15:08:00
mTor-2.0-Mm 2.0 2018-04-03 15:13:55
mTor-2.0-Rn 2.0 2018-04-03 15:19:47
Necroptosis-2.0-Hs 2.0 2018-04-03 15:06:02
Necroptosis-2.0-Mm 2.0 2018-04-03 15:11:58
Necroptosis-2.0-Rn 2.0 2018-04-03 15:17:45
NeuroMMSig AD GABA subgraph 5.0.4 2018-04-03 14:50:09
NeuroMMSig AD Low density lipoprotein subgraph 5.0.4 2018-04-03 14:50:18
NeuroMMSig AD Notch signaling subgraph 5.0.4 2018-04-03 14:50:14
NeuroMMSig AD Reactive oxygen species subgraph 5.0.4 2018-04-03 14:50:12
NeuroMMSigDB for Alzheimer Disease 20171205 2018-04-03 15:00:11
NeuroMMSigDB for Parkinson Disease 20171205 2018-04-03 15:02:05
Neurotransmitter and Insulin NeuroMMSig enrichments 0.0.1 2018-04-03 15:01:00
Neutrophil Signaling-2.0-Hs 2.0 2018-04-03 15:06:12
Neutrophil Signaling-2.0-Mm 2.0 2018-04-03 15:12:07
Neutrophil Signaling-2.0-Rn 2.0 2018-04-03 15:17:55
NFE2L2 Signaling-2.0-Hs 2.0 2018-04-03 15:05:50
NFE2L2 Signaling-2.0-Mm 2.0 2018-04-03 15:11:44
NFE2L2 Signaling-2.0-Rn 2.0 2018-04-03 15:17:32
NK Signaling-2.0-Hs 2.0 2018-04-03 15:05:56
NK Signaling-2.0-Mm 2.0 2018-04-03 15:11:51
NK Signaling-2.0-Rn 2.0 2018-04-03 15:17:38
Notch-2.0-Hs 2.0 2018-04-03 15:06:18
Notch-2.0-Mm 2.0 2018-04-03 15:12:14
Notch-2.0-Rn 2.0 2018-04-03 15:18:02
Nuclear Receptors-2.0-Hs 2.0 2018-04-03 15:06:24
Nuclear Receptors-2.0-Mm 2.0 2018-04-03 15:12:19
Nuclear Receptors-2.0-Rn 2.0 2018-04-03 15:18:08
Osmotic Stress-2.0-Hs 2.0 2018-04-03 15:06:30
Osmotic Stress-2.0-Mm 2.0 2018-04-03 15:12:25
Osmotic Stress-2.0-Rn 2.0 2018-04-03 15:18:14
Oxidative Stress-2.0-Hs 2.0 2018-04-03 15:06:41
Oxidative Stress-2.0-Mm 2.0 2018-04-03 15:12:36
Oxidative Stress-2.0-Rn 2.0 2018-04-03 15:18:25
PGE2-2.0-Hs 2.0 2018-04-03 15:06:48
PGE2-2.0-Mm 2.0 2018-04-03 15:12:43
PGE2-2.0-Rn 2.0 2018-04-03 15:18:33
Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease 0.1.0 2019-02-05 12:12:43
Project1 2.0.2 2018-12-11 04:35:06
Response to DNA Damage-2.0-Hs 2.0 2018-04-03 15:06:57
Response to DNA Damage-2.0-Mm 2.0 2018-04-03 15:12:52
Response to DNA Damage-2.0-Rn 2.0 2018-04-03 15:18:43
Selventa Named Complexes Definitions 20150611 2018-03-30 17:37:37
Selventa Protein Families Definitions 20150611 2018-03-30 17:37:14
Senescence-2.0-Hs 2.0 2018-04-03 15:07:05
Senescence-2.0-Mm 2.0 2018-04-03 15:13:00
Senescence-2.0-Rn 2.0 2018-04-03 15:18:52
Test1 1.1.1 2018-12-05 09:48:38
test_1 1.1.8 2018-12-06 05:19:09
test_2 1.1.13 2018-12-07 05:34:59
test_pr 1.1.6 2018-12-05 11:08:57
Th1-Th2 Signaling-2.0-Hs 2.0 2018-04-03 15:07:12
Th1-Th2 Signaling-2.0-Mm 2.0 2018-04-03 15:13:08
Th1-Th2 Signaling-2.0-Rn 2.0 2018-04-03 15:18:59
Th17 Signaling-2.0-Hs 2.0 2018-04-03 15:07:18
Th17 Signaling-2.0-Mm 2.0 2018-04-03 15:13:14
Th17 Signaling-2.0-Rn 2.0 2018-04-03 15:19:06
Tissue Damage-2.0-Hs 2.0 2018-04-03 15:07:24
Tissue Damage-2.0-Mm 2.0 2018-04-03 15:13:21
Tissue Damage-2.0-Rn 2.0 2018-04-03 15:19:12
Treg Signaling-2.0-Hs 2.0 2018-04-03 15:07:31
Treg Signaling-2.0-Mm 2.0 2018-04-03 15:13:28
Treg Signaling-2.0-Rn 2.0 2018-04-03 15:19:19
TREM2 and CD33 Mechanism 1.0.0 2018-04-03 15:01:55
Wnt-2.0-Hs 2.0 2018-04-03 15:07:37
Wnt-2.0-Mm 2.0 2018-04-03 15:13:34
Wnt-2.0-Rn 2.0 2018-04-03 15:19:25
Wound Healing-2.0-Hs 2.0 2018-04-03 15:07:46
Wound Healing-2.0-Mm 2.0 2018-04-03 15:13:43
Wound Healing-2.0-Rn 2.0 2018-04-03 15:19:33
Xenobiotic Metabolism Response-2.0-Hs 2.0 2018-04-03 15:07:54
Xenobiotic Metabolism Response-2.0-Mm 2.0 2018-04-03 15:13:50
Xenobiotic Metabolism Response-2.0-Rn 2.0 2018-04-03 15:19:41

Seeding

Please choose the seeding type your want to use for the query. Note: it's possible to use multiple seeding types.

Seeding by Nodes

This method of seeding will acquire the given nodes and expand around them using given seed method.

Use Case: The leukemia drug, nilotinib, triggers cells to get rid of faulty components - including the ones associated with several brain diseases. In 2015, Georgetown University Medical Center published findings that the drug had a helpful effect on patients in Alzheimer's and Parkinson's diseases. Though it is currently unknown, a search of the paths between this drug and these diseases could provide insight to nilotinib's mechanism of action.

Seeding by Name Search

This method acquires the nodes whose names are superstrings of the search query

Use Case: Users may be interested in a whole class of nodes related to a certain name, such as th MGI, RGD, HGNC, and HGNC Families related to AKT1.

Seeding by Authorship

This method acquires the nodes and edges asserted by the given authors and expands around their neighborhoods to show peripheral knowledge.

Use Case: Users may be interested in the representation of their own work, their colleagues' work, and their favorite publications in the knowledge assembly. For users that are new to a given field, this is an excellent research tool to identify what papers to read next.

Seeding by Citation

This method acquires the nodes and edges asserted by the given citations and expands around their neighborhoods to show peripheral knowledge.

Use Case: Users may be interested in the representation of their own work, their colleagues' work, and their favorite publications in the knowledge assembly. For users that are new to a given field, this is an excellent research tool to identify what papers to read next.

Seeding by Annotation

This method of will acquire edges matching any of the given annotations.

Use Case: The Amyloidogenic Cascade describes the processes resulting from amyloid beta peptides deposition in the brain; and is a central to Alzheimer Disease (AD) pathology. Using the NeuroMMSig functional annotations, this sub-network can be extracted and its periphery can be investigated to identify novel overlaps with other canonical pathways implicated in AD.

Transformations

Please choose any filters, enrichments, or transformations you want to apply to the query. For a list of available functions, please see here.

Use Case: You might want to collapse all protein, RNA, and miRNA nodes to their corresponding gene to simplify visualization and exploration.

About

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of the open source project, PyBEL. Please feel free to contact us here to give us feedback or report any issues.